2007
DOI: 10.1182/blood-2006-12-062398
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

29
346
2
4

Year Published

2008
2008
2014
2014

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 460 publications
(381 citation statements)
references
References 44 publications
(55 reference statements)
29
346
2
4
Order By: Relevance
“…Under pathologic conditions, miR-155 has been associated with a number of human neoplastic disorders. Studies have shown that miR-155 accumulates in chronic lymphocytic leukemia (34), lymphomas (30,35), breast cancer, and pancreatic cancer (36,37). Our findings extend the information on miR-155 expression in human cells by demonstrating its presence in synovial fibroblasts.…”
Section: Discussionsupporting
confidence: 81%
“…Under pathologic conditions, miR-155 has been associated with a number of human neoplastic disorders. Studies have shown that miR-155 accumulates in chronic lymphocytic leukemia (34), lymphomas (30,35), breast cancer, and pancreatic cancer (36,37). Our findings extend the information on miR-155 expression in human cells by demonstrating its presence in synovial fibroblasts.…”
Section: Discussionsupporting
confidence: 81%
“…Dysregulation of miRNA expression has been identified in a number of cancers (Pan et al, 2001;Lu et al, 2005;Volinia et al, 2006;Blenkiron et al, 2007;Chen and Stallings, 2007;Fulci et al, 2007;Gaur et al, 2007;Kummar et al, 2007;Meng et al, 2007;Porkka et al, 2007;Wedel et al, 2008) and an accumulating data indicate that some miRNAs can function as tumor suppressors or oncogenes and are important in cancer development. Deletion or loss of function of a tumor-suppressing miRNA results in overexpression of target oncogenes.…”
Section: Introductionmentioning
confidence: 99%
“…It is also reported to be up-regulated in hematological malignancies such as leukemia[2], lymphoma[3], and multiple myeloma[4]. miR-21 is overexpressed in glioblastoma[5], osteosarcoma [6], and spermatocytic seminoma[7].…”
mentioning
confidence: 99%